SFM
BIOA

Sphera Funds Management’s BioAge Labs BIOA Stock Holding History

Sphera Funds Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51M Sell
86,518
-156,517
-64% -$3.01M 0.24% 85
2025
Q4 		$3.22M Buy
+243,035
New +$2.15M 0.62% 59

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Sphera Funds Management's BIOA Position: Q1 2026 in Review

Sphera Funds Management reduced its BioAge Labs (BIOA) stake by 64% in Q1 2026, selling an estimated $3.01M and leaving 86,518 shares worth $1.51M. The position accounts for 0.24% of the portfolio, ranked #85.

Sphera Funds Management first reported a position in BIOA in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.22M in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Sphera Funds Management held 86,518 shares of BioAge Labs worth $1.51M as of Q1 2026.
  • Sphera Funds Management sold 156,517 BioAge Labs shares in Q1 2026, an estimated $3.01M.
  • BioAge Labs made up 0.24% of Sphera Funds Management's portfolio in Q1 2026, its #85 holding.
  • Sphera Funds Management first reported a position in BioAge Labs in Q4 2025 and has held it in 2 quarters since.
  • Sphera Funds Management's BioAge Labs position peaked at $3.22M in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.